Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001165527-10-000302
Filing Date
2010-04-15
Accepted
2010-04-15 16:39:16
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED 12-31-09 g3995a.txt 10-K 193386
2 CEO SECTION 302 CERTIFICATION ex31-1.txt EX-31.1 4313
3 CFO SECTION 302 CERTIFICATION ex31-2.txt EX-31.2 4290
4 CEO SECTION 906 CERTIFICATION ex32-1.txt EX-32.1 1554
5 CFO SECTION 906 CERTIFICATION ex32-2.txt EX-32.2 1532
  Complete submission text file 0001165527-10-000302.txt   206495
Mailing Address 303-1687 BROADWAY W VANCOUVER A1 V6J 1X2
Business Address 303-1687 BROADWAY W VANCOUVER A1 V6J 1X2 604-637-9744
Enox Biopharma Inc (Filer) CIK: 0001424860 (see all company filings)

EIN.: 260477124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53486 | Film No.: 10752407
SIC: 3841 Surgical & Medical Instruments & Apparatus